CYP2C18 Activators

The chemical class known as CYP2C18 Activators comprises a group of chemicals that can stimulate the activity and expression of the cytochrome P450 enzyme, CYP2C18. These activators work through various mechanisms to enhance the function of CYP2C18, which plays a vital role in drug metabolism and the biotransformation of endogenous compounds in the human body. One common mechanism through which CYP2C18 activators operate is by interacting with nuclear receptors. These chemicals, such as phenobarbital, rifampicin, carbamazepine, and phenytoin, bind to specific nuclear receptors, such as the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR). This binding activates these nuclear receptors, which subsequently promote the transcription of CYP2C18 genes. As a result, the expression of CYP2C18 is upregulated, leading to an increase in the enzyme's levels within the cell. This enhanced expression, in turn, can significantly boost the metabolic capacity of CYP2C18, allowing it to metabolize a wider range of substrates, including drugs and endogenous compounds.

In addition to nuclear receptor-mediated activation, some CYP2C18 activators, like omeprazole, leflunomide, trazodone, and tolbutamide, work indirectly by serving as substrates for the enzyme itself. These chemicals are metabolized by CYP2C18, and this metabolic process activates the enzyme. As they are processed by CYP2C18, they can induce its activity, making it more efficient in metabolizing other compounds. This indirect activation pathway contributes to the diverse ways in which CYP2C18 activators can enhance the enzyme's function.